Squamous cell carcinoma (SCC) antigen levels were studied in 34 patients with primary (N = 27) or recurrent (N = 7) SCC of the vulva. In primary disease, the SCC antigen level was greater than 2.5 ng/ml in only four patients ( 15 %) . Elevated antigen levels ranged from 2.7-1 8 .O ng/ml . All of the
Cerebellar metastasis in squamous cell vulvar carcinoma
β Scribed by Polat Dursun; Ali Ayhan; N. Cagla Tarhan; Gonca Coban; Esra Kuscu
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 198 KB
- Volume
- 279
- Category
- Article
- ISSN
- 0003-9128
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Our aim was to evaluate whether serum concentrations of squamous cell carcinoma antigen (SCC-Ag) are an independent prognostic factor in patients with vulvar cancer. We measured SCC-Ag in pretreatment serum samples of 55 patients with squamous cell vulvar cancer, 30 patients with vulvar intraepithel
## BACKGROUND. The antitubule agent paclitaxel causes a cell cycle blockage in the most radiosensitive part of the cell cycle, the GJM phase. The possible radiosensitizing effect of paclitaxel was tested in four vulvar (UM-SCV-lA, UM-SCV-lB, UM-SCV-2, and UM-SCV-4) squamous cell carcinoma (SCC) ce
## Background: The presence of regional metastasis in patients with head and neck squamous cell carcinoma (hnscc) is a common and adverse event associated with poor prognosis and high mortality. although significant improvements in standard therapies have increased the efficacy of local tumor manag
## Abstract Concurrent paclitaxel and radiation has given promising results in the treatment of a variety of solid tumors. We wanted to test the efficacy of this combination for vulvar carcinoma, which currently has a poor outcome in advanced stages. The radiation sensitivity, sublethal damage repa